MedTrace Logo

Automated Device for Asthma Monitoring and Management in Monitoring Adults With Lung Cancer Undergoing Radiation Therapy

NCT03340714 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2025-05-15

No results posted yet for this study

Summary

This pilot early phase I trial studies the Automated Device for Asthma Monitoring and Management in monitoring adult patients with lung cancer who are undergoing radiation therapy. The Automated Device for Asthma Monitoring and Management may provide useful information to doctors to help monitor adult patients with lung cancer and diagnose certain conditions earlier than traditional means.

Conditions

  • Lung Carcinoma

Interventions

DEVICE

Monitoring Device

Wear ADAMM

Sponsors & Collaborators

  • Health Care Originals, Inc.

    collaborator UNKNOWN

  • Sidney Kimmel Cancer Center at Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Maria Werner-Wasik, MD · Sidney Kimmel Cancer Center at Thomas Jefferson University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-20
Primary Completion
2021-10-25
Completion
2023-09-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03340714 on ClinicalTrials.gov